/Issuer/BBIO-US/Valuation

--:--:--ET

feed

S&P 500—

NASDAQ—

DOW—

VIX—

US10Y—

EUR/USD—

GOLD—

WTI—

BTC—

BBIO

BridgeBio Pharma, Inc.

HealthcareBiotechnologyUSUSDPeers →

$67.61

LiveJun 05, 2026

Market cap

$13.24B

52w range

37.69 – 84.94

P / E

—

EPS · FY 2025

$-3.79

Volume

2.59M

Revenue · FY 2025

$502.08M

+126.26% YoY

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Sentiment ESG

Explain this page

Arphra AIPlain-English read on BridgeBio Pharma, Inc.’s valuation

Pro

Valuation & DCF

Our full DCF model and fair-value breakdown is included with Pro.

Multi-scenario DCF with editable assumptions
Fair value vs market price
Reverse-DCF implied expectations

Upgrade to Pro Compare plans